IVUS-FFR Accuracy for Coronary Stenosis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorChina National Center for Cardiovascular Diseases

About this trial

IVUS-FFR Online Accuracy for Coronary Stenosis What is this study testing? This study is testing a new technology called IVUS-FFR , which uses ultrasound imaging inside heart arteries (IVUS) to quickly measure whether a narrowed artery ( coronary stenosis ) is reducing blood flow. Unlike the current standard test (FFR), this new method doesn't require extra wires or medication to work.

Why is this important?

Many patients with heart artery narrowing need tests to decide if a stent is necessary.

Current FFR tests involve inserting a pressure wire and giving medication (like adenosine) that can cause discomfort.

IVUS-FFR could provide equally accurate results faster, cheaper, and more comfortably .

What happens in the study?

If you join:

Standard heart artery imaging (angiogram) will be performed. An ultrasound probe (IVUS) will be moved through the artery to create detailed images.

The new IVUS-FFR software will analyze these images immediately to estimate blood flow.

For comparison, a standard FFR test (with pressure wire and medication) will also be done.

All steps use existing approved devices and take \<10 extra minutes. Who can participate?

Adults (≥18 years) with:

Suspected or known heart artery disease At least one artery narrowing (30%-90% blocked) Excluded: Recent heart attack (\<72 hrs), severe kidney/heart failure, or pregnancy.

What are the risks and benefits?

Risks: Same as routine heart catheterization (bleeding, infection, artery injury). The IVUS and FFR steps add minimal extra risk.

Benefits: No direct benefit, but results may improve future care by reducing need for invasive tests.

Study goal:

To validate if IVUS-FFR is as accurate as the current FFR standard in 292 patients across multiple hospitals in China.

Who is running the study? Led by heart specialists at Fuwai Hospital (Beijing) - China's top cardiovascular center - with ethics committee oversight.

Eligibility criteria

Qualifiers

18 years of age Diagnosed with stable/unstable angina or post-acute phase myocardial infarction (>72 hours after onset) Able to comprehend study design and provide written informed consent Angiographic & IVUS-Specific Requirements

1 epicardial coronary artery with 30%-90% visual diameter stenosis Reference vessel diameter ≥2.0 mm at target stenosis site

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Ultrasound-Derived Fractional Flow Reserve Computational System

Treatment groups

292 Participants
are divided into 1 treatment group